Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.76
-0.33 (-1.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Immunome Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,812 | 663 | 457 | 27 | 157 | 102 | |
| Market Cap Growth | 209.20% | 44.98% | 1605.70% | -82.91% | 53.68% | - | |
| Enterprise Value | 1,544 | 425 | 367 | -0 | 101 | 151 | |
| Last Close Price | 19.76 | 10.62 | 10.70 | 2.21 | 12.96 | 9.68 | |
| PS Ratio | 161.95 | 73.32 | 32.62 | - | - | - | |
| PB Ratio | 6.87 | 3.66 | 3.81 | 1.61 | 3.26 | 2.47 | |
| P/TBV Ratio | 6.87 | 3.66 | 3.81 | 1.61 | 3.26 | 2.47 | |
| EV/Sales Ratio | 159.48 | 47.06 | 26.18 | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.01 | 0.02 | - | 0.02 | |
| Asset Turnover | 0.04 | 0.05 | 0.16 | - | - | - | |
| Quick Ratio | 8.67 | 4.00 | 6.33 | 2.89 | 5.50 | 13.37 | |
| Current Ratio | 8.90 | 4.08 | 6.63 | 3.09 | 5.82 | 14.12 | |
| Return on Equity (ROE) | -93.04% | -194.63% | -156.45% | -113.81% | -55.20% | -79.97% | |
| Return on Assets (ROA) | -46.48% | -49.34% | -20.81% | -56.27% | -30.75% | -30.91% | |
| Return on Capital (ROIC) | -53.25% | -62.38% | -25.93% | -70.82% | -34.95% | -33.47% | |
| Return on Capital Employed (ROCE) | -77.20% | -82.50% | -22.70% | -220.80% | -52.30% | -29.60% | |
| Earnings Yield | -12.29% | -44.20% | -23.36% | -137.65% | -15.76% | -17.48% | |
| FCF Yield | -10.59% | -17.80% | -1.84% | -107.96% | -11.67% | -12.46% | |
| Buyback Yield / Dilution | -47.92% | -195.51% | -63.64% | -5.10% | -240.41% | -209.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.